(ORI) Old Republic International - Overview
Sector: Financial Services | Industry: Insurance - Property & Casualty | Exchange: NYSE (USA) | Market Cap: 9.577m USD | Total Return: 11.8% in 12m
Industry Rotation: +12.1
Avg Turnover: 46.8M
EPS Trend: 43.3%
Qual. Beats: -2
Rev. Trend: 72.4%
Qual. Beats: 2
Warnings
Choppy
Tailwinds
No distinct edge detected
Old Republic International Corporation (ORI) is a Chicago-based insurance holding company that operates through two primary divisions: Specialty Insurance and Title Insurance. The Specialty Insurance segment provides a broad range of commercial liability, workers compensation, and indemnity products tailored to industries such as transportation, healthcare, and construction. The Title Insurance segment offers protection against real estate title defects and provides ancillary services, including escrow and closing management.
The company utilizes a decentralized business model, allowing its subsidiaries to specialize in niche markets while maintaining centralized capital management. In the title insurance sector, revenue is heavily cyclical and closely tied to the volume of residential and commercial real estate transactions and refinancing activity. For a deeper analysis of these cyclical trends, consult the latest reports on ValueRay. Founded in 1923, the firm maintains a diverse portfolio that mitigates risk across various property and casualty sub-sectors.
- Commercial real estate transaction volume dictates Title Insurance segment revenue growth
- Mortgage interest rate fluctuations impact residential title insurance demand and margins
- Transportation and construction sector strength drives Specialty Insurance premium volume
- Workers compensation loss ratios and medical inflation affect overall underwriting profitability
- Investment portfolio yield sensitivity to federal interest rate policy moves net income
| Net Income: 1.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.95 > 1.0 |
| NWC/Revenue: -12.98% < 20% (prev 110.4%; Δ -123.3% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.21b > Net Income 1.02b |
| Net Debt (1.39b) to EBITDA (1.34b): 1.03 < 3 |
| Current Ratio: 0.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (249.6m) vs 12m ago 0.0% < -2% |
| Gross Margin: 51.14% > 18% (prev 0.63%; Δ 5.05k% > 0.5%) |
| Asset Turnover: 37.73% > 50% (prev 29.72%; Δ 8.02% > 0%) |
| Interest Coverage Ratio: 18.42 > 6 (EBITDA TTM 1.34b / Interest Expense TTM 70.0m) |
| A: -0.06 (Total Current Assets 2.99b - Total Current Liabilities 4.20b) / Total Assets 21.65b |
| B: 0.26 (Retained Earnings 5.65b / Total Assets 21.65b) |
| C: 0.05 (EBIT TTM 1.29b / Avg Total Assets 24.84b) |
| D: 0.38 (Book Value of Equity 5.94b / Total Liabilities 15.73b) |
| Altman-Z'' Score: 1.23 = BB |
| DSRI: 0.27 (Receivables 2.78b/9.27b, Revenue 9.37b/8.33b) |
| GMI: 1.23 (GM 51.14% / 62.76%) |
| AQI: 1.62 (AQ_t 0.85 / AQ_t-1 0.53) |
| SGI: 1.13 (Revenue 9.37b / 8.33b) |
| TATA: -0.01 (NI 1.02b - CFO 1.21b) / TA 21.65b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
Over the past week, the price has changed by +1.02%, over one month by -6.87%, over three months by -3.95% and over the past year by +11.77%.
- StrongBuy: 0
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 42 | 6.1% |
P/E Forward = 11.4286
P/S = 1.0165
P/B = 1.6174
P/EG = 1.39
Revenue TTM = 9.37b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.34b USD
Long Term Debt = 1.59b USD (from longTermDebt, last quarter)
Short Term Debt = 52.3m USD (from shortTermDebt, last fiscal year)
Debt = 1.59b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.39b USD (from netDebt column, last quarter)
Enterprise Value = 10.96b USD (9.58b + Debt 1.59b - CCE 202.1m)
Interest Coverage Ratio = 18.42 (Ebit TTM 1.29b / Interest Expense TTM 70.0m)
EV/FCF = 9.03x (Enterprise Value 10.96b / FCF TTM 1.21b)
FCF Yield = 11.07% (FCF TTM 1.21b / Enterprise Value 10.96b)
FCF Margin = 12.95% (FCF TTM 1.21b / Revenue TTM 9.37b)
Net Margin = 10.89% (Net Income TTM 1.02b / Revenue TTM 9.37b)
Gross Margin = 51.14% ((Revenue TTM 9.37b - Cost of Revenue TTM 4.58b) / Revenue TTM)
Gross Margin QoQ = 64.98% (prev 11.98%)
Tobins Q-Ratio = 0.51 (Enterprise Value 10.96b / Total Assets 21.65b)
Interest Expense / Debt = 1.11% (Interest Expense 17.7m / Debt 1.59b)
Taxrate = 20.27% (83.8m / 413.4m)
NOPAT = 1.03b (EBIT 1.29b * (1 - 20.27%))
Current Ratio = 0.71 (Total Current Assets 2.99b / Total Current Liabilities 4.20b)
Debt / Equity = 0.27 (Debt 1.59b / totalStockholderEquity, last quarter 5.91b)
Debt / EBITDA = 1.03 (Net Debt 1.39b / EBITDA 1.34b)
Debt / FCF = 1.14 (Net Debt 1.39b / FCF TTM 1.21b)
Total Stockholder Equity = 6.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.11% (Net Income 1.02b / Total Assets 21.65b)
RoE = 16.72% (Net Income TTM 1.02b / Total Stockholder Equity 6.11b)
RoCE = 16.74% (EBIT 1.29b / Capital Employed (Equity 6.11b + L.T.Debt 1.59b))
RoIC = 13.35% (NOPAT 1.03b / Invested Capital 7.70b)
WACC = 5.68% (E(9.58b)/V(11.17b) * Re(6.47%) + D(1.59b)/V(11.17b) * Rd(1.11%) * (1-Tc(0.20)))
Discount Rate = 6.47% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -88.19 | Cagr: -4.55%
[DCF] Terminal Value 86.22% ; FCFF base≈1.25b ; Y1≈1.24b ; Y5≈1.28b
[DCF] Fair Price = 150.5 (EV 38.05b - Net Debt 1.39b = Equity 36.66b / Shares 243.6m; r=6.0% [WACC]; 5y FCF grow -2.04% → 3.0% )
EPS Correlation: 43.34 | EPS CAGR: -0.39% | SUE: -1.08 | # QB: -2
Revenue Correlation: 72.39 | Revenue CAGR: 7.81% | SUE: 1.30 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.80 | Chg30d=-4.01% | Revisions=-14% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.80 | Chg30d=+1.27% | Revisions=+14% | Analysts=3
EPS current Year (2026-12-31): EPS=3.07 | Chg30d=-7.07% | Revisions=-43% | GrowthEPS=-2.6% | GrowthRev=+9.0%
EPS next Year (2027-12-31): EPS=3.33 | Chg30d=-4.31% | Revisions=-33% | GrowthEPS=+8.7% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: -43%